Alvimedica is a young, agile company devoted to developing minimally-invasive medical technologies for medical professionals looking for the next level of innovation in the operating room.
Alvimedica is a manufacturer of coronary stents, balloon catheters, diagnostic and guiding catheters. The company was founded in 2007 by Turkish businessmen and scientists living in Denmark and Sweden.
Celltrion is Korea’s leading biologics company dedicated to research, development, and manufacture of
both biosimilars and new biopharmaceutical products, with a commitment of contributing to the
promotion of human health and social welfare.
CID S.p.A. facility is designed for the manufacture of medical devices consistently with the requirements of Standards ISO 9001:2008 “Quality Management Systems – Requirements” and ISO 13485:2012 “Medical devices – Quality management systems – Requirements for regulatory purpose”.
The manufacturing is based on Coronary BMS and DES stents, balloons, coronary catheters, and endovascular stents according to the Good Manufacturing Practices (GMP) criteria.
Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system.
Cardiome’s mission is to offer patients and health care providers innovative therapeutic options that effectively, safely, and conveniently manage acute medical conditions to improve health and quality of life.
Ferring is a biopharmaceutical company dedicated to the development of innovative treatments that make a real difference in people’s lives all over the world. Active in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics, we develop medicine on the body’s own terms.
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients.
Our product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the medical devices for administering these products.
Helsinn has become one of the world’s leading supportive cancer care companies, with a comprehensive portfolio of oncology products and therapies helping to improve the lives of patients in 90 countries worldwide. We work with a host of longstanding worldwide partners who share our vision and values, with a unique business model combining integrated early- and late-stage licensing programmes to complement our own drug discovery and development
With a footprint spanning more than 100 countries around the world, Laboratoire INNOTECH International specializes in the design and marketing of health products, medical devices, and pharmaceuticals which are designed to treat every-day pathologies including gynaecological disorders, venous insufficiency, anaemia, and mineral deficiencies.
Ipsen is a global specialty driven pharmaceutical company with a significant presence in primary care. Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in over 30 countries worldwide. The Group has more than 4,900 employees all over the world.
Medinova AG develops and manufactures prescription and over- the-counter pharmaceutical products primarily in the areas of gynecology and dermatology. The company offers products for vaginal healthcare, skincare, insomnia, phelebology, pregnancy and nutrition, gastroenterology, and rheumatology. Medinova markets its products in Switzerland and internationally.
Rohto Pharmaceutical Co., Ltd. is a multinational fast-moving consumer goods and OTC pharmaceutical corporation headquartered in Ikuno-ku, Osaka, Japan, with a presence in North America, Europe and Asia. Since its founding, Rohto has developed a wide range of products, from digestive medicines, to eye drops, dermatological ointment (such as Mentholatum), and from the year 2000, beauty products such as “Obagi” and “Hada-Labo”
